Conversely, the loss of PKP1 or its cytoplasmic localization is indicative of tumor dedifferentiation, increased invasiveness, and poorer patient outcomes (Papagerakis et al., 2003; Moll et al., 1997). Here, PKP1 is linked to neoplasm.